scholarly journals Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical Practice

2021 ◽  
Author(s):  
Lishi Lin ◽  
Egbert F. Smit ◽  
Adrianus J. de Langen ◽  
Dorieke E. M. van Balen ◽  
Jos H. Beijnen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Practice ◽  
Treatment Outcomes ◽  
Cancer Patients ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Trial ◽  
Lung Cancer Patients ◽  
Egfr Mutated

scholarly journals P3.02c-089 ImmunoCHIC: A Prospective Nivolumab Monotherapy Cohort in Advanced Non-Small Cell Lung Cancer Patients in Routine Clinical Practice

2017 ◽  
Vol 12 (1) ◽  
pp. S1332-S1333
Author(s):  
Shobanya Elvarathnam ◽  
Christos Chouaid ◽  
Nadine Thiriat. ◽  
Laurence Jabot ◽  
Gaelle Rousseau-Bussac ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Practice ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Routine Clinical Practice ◽  
Small Cell Lung ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document